Merck & Co. Inc. (MRK): Price and Financial Metrics

Merck & Co. Inc. (MRK): $87.14

0.27 (+0.31%)

POWR Rating

Component Grades














  • MRK scores best on the Quality dimension, with a Quality rank ahead of 90.26% of US stocks.
  • MRK's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • MRK's current lowest rank is in the Momentum metric (where it is better than 17.51% of US stocks).

MRK Stock Summary

  • MRK has a market capitalization of $218,926,044,205 -- more than approximately 99.4% of US stocks.
  • MERCK & CO INC's stock had its IPO on January 1, 1986, making it an older stock than 93.28% of US equities in our set.
  • In terms of twelve month growth in earnings before interest and taxes, MERCK & CO INC is reporting a growth rate of 166.21%; that's higher than 90.24% of US stocks.
  • If you're looking for stocks that are quantitatively similar to MERCK & CO INC, a group of peers worth examining would be PFE, NVS, CSCO, AZN, and NVO.
  • MRK's SEC filings can be seen here. And to visit MERCK & CO INC's official web site, go to

MRK Valuation Summary

  • MRK's EV/EBIT ratio is 13.2; this is 22.22% higher than that of the median Healthcare stock.
  • Over the past 243 months, MRK's price/sales ratio has gone up 1.7.

Below are key valuation metrics over time for MRK.

Stock Date P/S P/B P/E EV/EBIT
MRK 2022-09-01 3.9 5.1 13.3 13.2
MRK 2022-08-31 3.8 5.0 13.0 12.9
MRK 2022-08-30 3.8 5.1 13.3 13.1
MRK 2022-08-29 3.9 5.1 13.4 13.2
MRK 2022-08-26 4.0 5.2 13.6 13.4
MRK 2022-08-25 4.0 5.3 13.8 13.6

MRK Growth Metrics

    Its year over year price growth rate is now at 13.27%.
  • Its 3 year net cashflow from operations growth rate is now at 53.82%.
  • Its year over year cash and equivalents growth rate is now at 22.56%.
Over the past 70 months, MRK's revenue has gone up $17,262,000,000.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 57,169 18,891 16,579
2022-03-31 53,978 17,079 14,180
2021-12-31 48,704 14,109 13,049
2021-09-30 49,151 13,084 7,197
2021-06-30 48,548 10,460 5,571
2021-03-31 48,018 11,337 7,028

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
  • MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
  • XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.535 0.675 0.129
2021-03-31 0.529 0.670 0.158
2020-12-31 0.538 0.677 0.171
2020-09-30 0.542 0.712 0.276
2020-06-30 0.550 0.701 0.260
2020-03-31 0.571 0.701 0.256

MRK Price Target

For more insight on analysts targets of MRK, see our MRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $93.38 Average Broker Recommendation 1.52 (Moderate Buy)

MRK Stock Price Chart Interactive Chart >

Price chart for MRK

MRK Price/Volume Stats

Current price $87.14 52-week high $95.72
Prev. close $86.87 52-week low $70.89
Day low $86.13 Volume 2,373,961
Day high $87.16 Avg. volume 11,188,310
50-day MA $90.20 Dividend yield 3.18%
200-day MA $84.17 Market Cap 220.75B

Merck & Co. Inc. (MRK) Company Bio

Merck & Co., Inc.d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.(Source:Wikipedia)

MRK Latest News Stream

Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream

Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about MERCK & CO INC that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.

Yahoo | September 7, 2022

10 Best Cheap Stocks to Buy Now

In this article, we discuss the 10 best cheap stocks to buy right now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Cheap Stocks to Buy Right Now. With rising interest rates and fears of recession, the stock market has been volatile in 2022. Additionally, the […]

Yahoo | September 7, 2022

Target CEO Brian Cornell to Stay Three More Years

The retailer’s board eliminated its mandatory retirement age of 65 for the CEO, who turns 64 next year.

Yahoo | September 7, 2022

Merck's Deal With Seagen May Have Fallen Through. Now What?

Following months of speculation over pharmaceutical giant Merck's (NYSE: MRK) potential takeover of cancer-focused biotech Seagen (NASDAQ: SGEN), reports are now surfacing that the two companies couldn't reach an agreement over pricing. Merck has one of the premier oncology franchises in the industry and sells $17 billion of industry-leading cancer drug Keytruda. The drug is approved for at least 14 different types of cancer, and its sales just keep growing.

Yahoo | September 7, 2022

Merck to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

RAHWAY, N.J., September 06, 2022--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M. Davis, chief executive officer and president, and Dr. Dean Li, president, Merck Research Laboratories, are scheduled to participate in a virtual fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, Sept. 12, 2022, at 2:15 p.m. EDT.

Yahoo | September 6, 2022

Read More 'MRK' Stories Here

MRK Price Returns

1-mo -2.66%
3-mo 0.77%
6-mo 13.26%
1-year 19.79%
3-year 15.08%
5-year 58.58%
YTD 15.65%
2021 -2.91%
2020 -7.20%
2019 22.27%
2018 39.95%
2017 -1.49%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7339 seconds.